Home / Education / Education Courses / Child & Adolescent Psychopharmacology 2022

Child & Adolescent Psychopharmacology 2022

Event Date(s): Mar 18, 2022 - 07:45am to Mar 20, 2022 - 04:40pm

Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. These area include new diagnostic criteria, patient-centered care models, new trends in substance abuse, research advances on genetics, and much more. It is more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes.

Available Credits: 18.75 AMA PRA Category 1 Credit™ 18.75 Nursing Contact Hours 18.75 Social Workers 18.75 Participation 18.75 Psychologists CE Credit Register For This Course

Course Details

Now Virtual!

Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. These area include new diagnostic criteria, patient-centered care models, new trends in substance abuse, research advances on genetics, and much more. It is more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes.

That's why it's critical to attend this hands-on, comprehensive conference. It provides psychiatrists, pediatricians, primary care and family practice physicians, nursing professionals, psychologists, social workers, and other mental health professionals with insights to optimize your assessment, treatment, and management of child and adolescent patients with psychiatric conditions.

  • Meet and engage face-to-face with renowned clinician-researchers who share the latest advances in their fields
  • Find guidance for complex signs and symptoms such as emotional outbursts, mood swings, and strange eating habits that can be indicative of psychiatric disorders yet can also be part of normal child development
  • Translate the latest research into optimal assessment and treatment strategies for anxiety, substance abuse, depression, eating disorders, OCD, psychosis, and much more

Conference will be held in Eastern Standard Time (EST).

Check back for CME information!

Pricing

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before January 15, 2022): $595.00
Early Bird Registration (January 15-February 15, 2022): $695.00
Regular Registration (after February 15, 2022): $795.00

Other Professionals or Trainees
Super Early Bird Registration (on or before January 15, 2022): $495.00
Early Bird Registration (January 15-February 15, 2022): $595.00
Regular Registration (after February 15, 2022): $695.00

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by February 26, 2021.  No refunds will be issued for refund requests made after February 26, 2021. Payments made may not be applied to future conferences or other educational activities.  There are no exceptions to these policies.

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.

Syllabus

E-SYLLABUS
We provide all attendees registered for the 3 day conference with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 
 

Course Summary

Available Credits:18.75 AMA PRA Category 1 Credit™ 18.75 Nursing Contact Hours 18.75 Social Workers 18.75 Participation 18.75 Psychologists CE Credit
Course Topic:Child & Family, Cognitive Behavioral Therapy
Course Format:Conference / meeting
Target Audience:
  • Psychiatrists
  • Primary care and family practice physicians
  • Pediatricians
  • Psychologists
  • Nursing professionals
  • Social workers
  • Residents
  • Other mental health, primary care and pediatric clinicians
Event Starts: Mar 18, 2022 - 07:45am
Event Ends: Mar 20, 2022 - 04:40pm
Cost: $795.00

Learning Objectives

  • Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence.
  • Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
  • Discuss the presentation, diagnosis, and current treatment options available for depression, psychosis, manic depression, and anxiety.
  • Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
  • Recognize the risk management issues associated with adolescent substance use disorder and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.
  • Review the comorbidity of ADHD with post-traumatic stress disorder and traumatic brain injury.
  • Explore emotional dysregulation, executive function and learning disorders in the context of ADHD.
  • Describe the relationship between antidepressants and suicide risk.
  • Discuss the available naturopathic treatments for emotional dysregulation in youth, including pros, cons, and available evidence.
  • Examine the evidence base for the Pediatric Autoimmune Neurological Disorder Associated with Streptococcus symptoms and its relation to OCD.
  • Describe the presentation, diagnosis, and current treatment options available for childhood onset schizophrenia.
  • Compare and contrast psychotherapeutic treatment approaches for children including DBT, CBT, and others.
  • Explore how animal models provide insight into child and adolescent psychiatric conditions, using ADHD as a model system.
  • Compare and contrast emotional dysregulation from mania, including presentation, course, and treatment.
  • Examine the relationship between learning disorders and ADHD.
  • Describe adult ADHD and discuss the controversies surrounding its diagnosis and treatment.
  • Examine the legal issues involved in treating individuals with ADHD and related disorders.
  • Describe the problems associated with treatment non-adherence and provide strategies to improve adherence in the clinical setting.